RTW Biotech Opportunities (LON:RTW – Get Free Report)’s stock price fell 0.7% on Wednesday . The stock traded as low as GBX 1.47 ($0.02) and last traded at GBX 1.47 ($0.02). 98,745 shares changed hands during mid-day trading, a decline of 80% from the average session volume of 504,050 shares. The stock had previously closed at GBX 1.48 ($0.02).
RTW Biotech Opportunities Price Performance
The stock has a market cap of £5.07 million, a P/E ratio of 4.11 and a beta of 0.60. The stock has a 50-day simple moving average of GBX 1.53 and a 200-day simple moving average of GBX 1.52.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Stories
- Five stocks we like better than RTW Biotech Opportunities
- Why Are Stock Sectors Important to Successful Investing?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Why Invest in High-Yield Dividend Stocks?
- 3 Penny Stocks Ready to Break Out in 2025
- 10 Best Airline Stocks to Buy
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
